Literature DB >> 12739797

Secretory and humoral antibody responses to Blastocystis hominis in symptomatic and asymptomatic human infections.

Manal S E Mahmoud1, Wafaa A Saleh.   

Abstract

The study included 3 groups of individuals, in the first 2 groups they had positive stool microscopic examinations only for B. hominis indicating blastocystosis, with and without gastrointestinal symptoms, respectively, while the last group included apparently healthy individuals with no parasites in stool. Stool and serum samples of these individuals were subjected to detection of anti-B. hominis fecal and serum IgA and serum IgG antibodies by indirect ELISA, and detection of B. hominis fecal and serum antigens by double sandwich ELISA. In symptomatic B. hominis infections with positive stool microscopy the study recorded first: specific secretory IgA and humoral IgA and IgG antibody responses at a prevalence of 100%, 83.3% and 86.6%, respectively, with an increased significant difference (P<0.001) of each from healthy controls, together with an increase in level of secretory IgA than that of humoral IgA antibody (P<0.001), and second: the presence of specific antigens in stool and serum at a prevalence of 96.6% and 90%, respectively. With an increased significant difference (P<0.001) of each from healthy controls together with the former at a higher level than the latter (P<0.05). In asymptomatic B. hominis infections with positive stool microscopy the study recorded first; absence of each of the studied specific secretory and humoral antibody responses with no significant difference (P>0.05) of each from healthy controls, and second; absence of specific antigens in stool and serum with no significant difference (P>0.05) of each from healthy controls nor from each other. The explanations and implications of these results are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739797

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  8 in total

1.  A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism.

Authors:  Haris Mirza; Zhaona Wu; Fahad Kidwai; Kevin S W Tan
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Immunopathological assessments of human Blastocystis spp. in experimentally infected immunocompetent and immunosuppresed mice.

Authors:  Ekhlas H Abdel-Hafeez; Azza K Ahmad; Noha H Abdelgelil; Manal Z M Abdellatif; Amany M Kamal; Kamel M A Hassanin; Abdel-Razik H Abdel-Razik; Ehab M Abdel-Raheem
Journal:  Parasitol Res       Date:  2016-02-10       Impact factor: 2.289

3.  Current Views on the Clinical Relevance of Blastocystis spp.

Authors:  Kevin S W Tan; Haris Mirza; Joshua D W Teo; Binhui Wu; Paul A Macary
Journal:  Curr Infect Dis Rep       Date:  2010-01       Impact factor: 3.725

Review 4.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

5.  Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls.

Authors:  Robyn Nagel; Rebecca J Traub; Marcella M S Kwan; Helle Bielefeldt-Ohmann
Journal:  Parasit Vectors       Date:  2015-09-15       Impact factor: 3.876

6.  Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNFα, IL-6, IL-10, IL-4).

Authors:  Mojtaba Norouzi; Majid Pirestani; Ehsan Arefian; Abdolhossein Dalimi; Javid Sadraei; Hamed Mirjalali
Journal:  Front Med (Lausanne)       Date:  2022-08-11

7.  Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection.

Authors:  Kenneth F Boorom; Huw Smith; Laila Nimri; Eric Viscogliosi; Gregory Spanakos; Unaiza Parkar; Lan-Hua Li; Xiao-Nong Zhou; Ulgen Z Ok; Saovanee Leelayoova; Morris S Jones
Journal:  Parasit Vectors       Date:  2008-10-21       Impact factor: 3.876

Review 8.  Update on the pathogenic potential and treatment options for Blastocystis sp.

Authors:  Tamalee Roberts; Damien Stark; John Harkness; John Ellis
Journal:  Gut Pathog       Date:  2014-05-28       Impact factor: 4.181

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.